Insider Buying: AdvanSix Inc (ASIX) Director Purchases 715 Shares of Stock

AdvanSix Inc (NYSE:ASIX) Director Michael Marberry bought 715 shares of the company’s stock in a transaction dated Friday, March 23rd. The stock was bought at an average price of $34.97 per share, with a total value of $25,003.55. Following the acquisition, the director now owns 18,911 shares in the company, valued at approximately $661,317.67. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Michael Marberry also recently made the following trade(s):

How to Become a New Pot Stock Millionaire
  • On Thursday, March 8th, Michael Marberry bought 574 shares of AdvanSix stock. The stock was bought at an average price of $43.51 per share, with a total value of $24,974.74.

AdvanSix Inc (NYSE ASIX) traded up $0.69 on Monday, reaching $34.76. The company had a trading volume of 265,125 shares, compared to its average volume of 316,559. AdvanSix Inc has a one year low of $24.72 and a one year high of $46.51. The company has a current ratio of 1.31, a quick ratio of 0.87 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1,038.52, a PE ratio of 7.40 and a beta of 0.62.

AdvanSix (NYSE:ASIX) last posted its quarterly earnings data on Friday, February 23rd. The company reported $0.60 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.10. AdvanSix had a return on equity of 32.17% and a net margin of 9.94%. The company had revenue of $370.39 million during the quarter, compared to analysts’ expectations of $365.40 million. The company’s revenue was up 42.8% on a year-over-year basis. sell-side analysts anticipate that AdvanSix Inc will post 3.28 EPS for the current fiscal year.

A number of equities analysts have recently commented on ASIX shares. ValuEngine upgraded AdvanSix from a “hold” rating to a “buy” rating in a report on Wednesday, January 10th. Zacks Investment Research upgraded AdvanSix from a “sell” rating to a “hold” rating in a report on Friday, March 16th.

Institutional investors and hedge funds have recently bought and sold shares of the stock. American International Group Inc. raised its position in AdvanSix by 5.7% during the 3rd quarter. American International Group Inc. now owns 23,789 shares of the company’s stock valued at $946,000 after purchasing an additional 1,287 shares in the last quarter. Raymond James & Associates raised its position in AdvanSix by 4.7% during the 4th quarter. Raymond James & Associates now owns 30,430 shares of the company’s stock valued at $1,280,000 after purchasing an additional 1,369 shares in the last quarter. Driehaus Capital Management LLC raised its position in AdvanSix by 2.3% during the 4th quarter. Driehaus Capital Management LLC now owns 103,128 shares of the company’s stock valued at $4,339,000 after purchasing an additional 2,284 shares in the last quarter. Macquarie Group Ltd. bought a new stake in AdvanSix during the 3rd quarter valued at $123,000. Finally, Globeflex Capital L P raised its position in AdvanSix by 5.5% during the 4th quarter. Globeflex Capital L P now owns 61,786 shares of the company’s stock valued at $2,599,000 after purchasing an additional 3,226 shares in the last quarter. Institutional investors own 77.96% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/3303278/insider-buying-advansix-inc-asix-director-purchases-715-shares-of-stock.html.

AdvanSix Company Profile

AdvanSix Inc is an integrated manufacturer of Nylon 6. The Company also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process primarily, including caprolactam, ammonium sulfate fertilizers and other chemical intermediates. The Company operates primarily through its integrated manufacturing sites located in Frankford, Pennsylvania, Hopewell, Virginia, and Chesterfield, Virginia.

Insider Buying and Selling by Quarter for AdvanSix (NYSE:ASIX)

Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Analysts Anticipate Clementia Pharmaceuticals  Will Post Earnings of -$0.33 Per Share
Zacks: Analysts Anticipate Clementia Pharmaceuticals Will Post Earnings of -$0.33 Per Share
1347 PIH  Receiving Somewhat Positive Media Coverage, Accern Reports
1347 PIH Receiving Somewhat Positive Media Coverage, Accern Reports
Good Times Burgers & Frozen Custard  Getting Somewhat Favorable Press Coverage, Analysis Finds
Good Times Burgers & Frozen Custard Getting Somewhat Favorable Press Coverage, Analysis Finds
First Community Co. to Issue Quarterly Dividend of $0.10
First Community Co. to Issue Quarterly Dividend of $0.10
RiverFront Dynamic US Flex-Cap ETF  Plans Monthly Dividend of $0.01
RiverFront Dynamic US Flex-Cap ETF Plans Monthly Dividend of $0.01
Rogers Communications  to Issue Quarterly Dividend of $0.48
Rogers Communications to Issue Quarterly Dividend of $0.48


© 2006-2018 Ticker Report. Google+.